K., Pal, T
Recent investigations have highlighted a link between the administration of DXN and an elevated mortality rate in specific patient groups
Licensure, prescription handling, pharmacist responsibility, ingredient sourcing, quality systems, and state oversight cannot be replaced with a laboratory report or marketing disclaimer
As with any dietary supplement, you should consult with a qualified healthcare professional if you are pregnant or nursing, if you have any medical condition, or if you are taking any medication before using this product
Regulatory Status and Safety Takeaway FDA Status: IGF-1 LR3 is not approved by the FDA for human therapeutic use and is highly restricted
It has also been associated with upregulation of growth-hormone receptors in tendon fibroblasts, a finding that may help explain reported effects on tendon and ligament tissue